Many patients with TIA are not receiving guideline-recommended secondary prevention measures such as dual antiplatelet therapy and lipid-lowering agents, an Australian study has found. The lack of adherence to guideline recommendation was particularly noticeable for TIA patients discharged from emergency departments, an audit carried out at the Royal Brisbane and Women’s Hospital revealed. Better communication ...
TIA patients not getting secondary prevention therapy
By Michael Woodhead
9 Feb 2021